The most recent Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Paolo Tarantino shared a post by Dana-Farber’s Breast Oncology Center on X, adding the following:

“Latest Breast Cancer Research Digest— powered by Dana-Farber’s Breast Oncology Center.”

Quoting Dana-Farber’s Breast Oncology Center’s post:

“Here’s the most recent Breast Cancer Research Digest – a summary of last week’s publications from select high-impact journals (June 2-9, 2024).”

Source: Paolo Tarantino/X and Dana-Farber’s Breast Oncology Center/X

Dr. Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.

His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a robust publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field. Dr. Tarantino’s dedication and innovative approach contribute significantly to the advancement of breast cancer treatment and research.